Extended Data Fig. 5: NanoString gene expression analysis of EMT6 tumors following treatment with nAlb-diABZI and AP-diABZI. | Nature Biomedical Engineering

Extended Data Fig. 5: NanoString gene expression analysis of EMT6 tumors following treatment with nAlb-diABZI and AP-diABZI.

From: Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates

Extended Data Fig. 5

Annotated matrices for (a) functional gene annotations, (b) biological signatures, and (c) cell types from IO360 Pan Cancer NanoString gene expression panel comparing PBS, nAlb-diABZI, and AP-diABZI 24 h after three doses (n = 3 for nAlb-diABZI; n = 4 for all other groups). P values determined by one-way ANOVA with post-hoc Tukey’s correction for multiple comparisons with comparison to PBS indicated. Replicates are biological.

Back to article page